Aytu BioScience (AYTU) Misses Q2 EPS by 105c

Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($1.05), $1.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $15.2 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Intel (INTC) call put ratio 1.2 calls to 1 put as share price down 3.3%
• Lettuce Grower Taylor Farms To Recall Products Tied To Outbreak - Bloomberg